Learn More
Medchemexpress LLC 6-(4-((5-chloro-4-((4-chlorophenyl)amino)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)-N-hydroxyhexanamide | 2284621-75-4 | 98.5% | 450.32 | C19H21Cl2N7O2 | 50MG

Supplier: Medchemexpress LLC HY12614150MG
JAK/HDAC-IN-1 is a small-molecule dual inhibitor of Janus kinases and histone deacetylases that exhibits low-nanomolar biochemical potency and antiproliferative, proapoptotic activity in hematological cell lines. The compound includes solubility and storage guidance for research applications and is provided as a high-purity research reagent.
- Dual JAK and HDAC inhibitory activity with low-nanomolar IC50s (example: JAK2 4 nM; HDAC 2 nM).
- Demonstrated antiproliferative and proapoptotic effects in hematological cell lines.
- Molecular formula C19H21Cl2N7O2; molecular weight 450.32.
- Soluble in DMSO (~20.83 mg/mL) and formulatable for in vivo dosing at ≥2.08 mg/mL in recommended vehicles.
- Storage: keep at 4°C protected from light; in solution store at -80°C (6 months) or -20°C (1 month) protected from light.
- Reported purity approximately 98.5%.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.